help button home button Am J Pathol ASIP 2008 Summer Academy, Molecular Methcanisms of Human Disease: Injury, Inflammation, and Tissue Repair
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zager, R. A.
Right arrow Articles by Kalhorn, T. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zager, R. A.
Right arrow Articles by Kalhorn, T. F.
(American Journal of Pathology. 2000;157:1007-1016.)
© 2000 American Society for Investigative Pathology

Regular Articles

Changes in Free and Esterified Cholesterol

Hallmarks of Acute Renal Tubular Injury and Acquired Cytoresistance

Richard A. Zager and Thomas F. Kalhorn

From the Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, Washington

Acute tubular cell injury is accompanied by plasma membrane phospholipid breakdown. Although cholesterol is a dominant membrane lipid which interdigitates with, and impacts, phospholipid homeostasis, its fate during the induction and recovery phases of acute renal failure (ARF) has remained ill defined. The present study was performed to ascertain whether altered cholesterol expression is a hallmark of evolving tubular damage. Using gas chromatographic analysis, free cholesterol (FC) and esterified cholesterol (CE) were quantified in: 1) isolated mouse proximal tubule segments (PTS) after 30 minutes of hypoxic or oxidant (ferrous ammonium sulfate) injury; 2) cultured proximal tubule (HK-2) cells after 4 or 18 hours of either ATP depletion/Ca2+ ionophore- or ferrous ammonium sulfate-mediated injury; and 3) in renal cortex 18 hours after induction of glycerol-induced myoglobinuric ARF, a time corresponding to the so-called "acquired cytoresistance" state (ie, resistance to further renal damage). Hypoxic and oxidant injury each induced ~33% decrements in CE (but not FC) levels in PTS, corresponding with lethal cell injury (~50 to 60% LDH release). When comparable CE declines were induced in normal PTS by exogenous cholesterol esterase treatment, proportionate lethal cell injury resulted. During models of slowly evolving HK-2 cell injury, progressive CE increments occurred: these were first noted at 4 hours, and reached ~600% by 18 hours. In vivo myoglobinuric ARF produced comparable renal cortical CE (and to a lesser extent FC) increments. Renal CE accumulation strikingly correlated with the severity of ARF (eg, blood urea nitrogen versus CE; r, 0.84). Mevastatin blocked cholesterol accumulation in injured HK-2 cells, indicating de novo synthesis was responsible. Acute tubule injury first lowers, then raises, tubule cholesterol content. Based on previous observations that cholesterol has cytoprotectant properties, the present findings have potential relevance for both the induction and maintenance phases of ARF.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
R. A. Zager, A. C. M. Johnson, M. Naito, and K. Bomsztyk
Maleate nephrotoxicity: mechanisms of injury and correlates with ischemic/hypoxic tubular cell death
Am J Physiol Renal Physiol, January 1, 2008; 294(1): F187 - F197.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
Y. Wang, A. H. Moser, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold
Downregulation of liver X receptor-{alpha} in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines
J. Lipid Res., November 1, 2005; 46(11): 2377 - 2387.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. G. Cutler, J. Kelly, K. Storie, W. A. Pedersen, A. Tammara, K. Hatanpaa, J. C. Troncoso, and M. P. Mattson
Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease
PNAS, February 17, 2004; 101(7): 2070 - 2075.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
R. A. Zager, A. C. M. Johnson, and S. Y. Hanson
Proximal tubular cholesterol loading after mitochondrial, but not glycolytic, blockade
Am J Physiol Renal Physiol, December 1, 2003; 285(6): F1092 - F1099.
[Abstract] [Full Text]

Home page
 Am. J. Pathol.Home page
R. A. Zager, A. C.M. Johnson, S. Y. Hanson, and V. O. Shah
Acute Tubular Injury Causes Dysregulation of Cellular Cholesterol Transport Proteins
Am. J. Pathol., July 1, 2003; 163(1): 313 - 320.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
H. Y. Li, F. R. Appelbaum, C. L. Willman, R. A. Zager, and D. E. Banker
Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses
Blood, May 1, 2003; 101(9): 3628 - 3634.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. C. M. Johnson, J. M. Yabu, S. Hanson, V. O. Shah, and R. A. Zager
Experimental Glomerulopathy Alters Renal Cortical Cholesterol, SR-B1, ABCA1, and HMG CoA Reductase Expression
Am. J. Pathol., January 1, 2003; 162(1): 283 - 291.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. A. Zager, V. O. Shah, H. V. Shah, P. G. Zager, A. C. M. Johnson, and S. Hanson
The Mevalonate Pathway during Acute Tubular Injury : Selected Determinants and Consequences
Am. J. Pathol., August 1, 2002; 161(2): 681 - 692.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. A. Zager, T. Andoh, and W. M. Bennett
Renal Cholesterol Accumulation : A Durable Response after Acute and Subacute Renal Insults
Am. J. Pathol., August 1, 2001; 159(2): 743 - 752.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society for Investigative Pathology.